KSM Feed

In the news

Thursday, 9th June 2022

Waning effectiveness of third dose of BNT162b2 vaccine.

COVID

Tuesday, 24th May 2022

Effectiveness of the 4th dose of Pfizer’s COVID-19 vaccine wanes after 10 weeks, sooner than previous doses.

Sunday, 27th March 2022

Our Deputy Head Dr. Sivan Gazit on Channel 13 evening news.

Sunday, 27th February 2022

Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections.

Tuesday, 15th February 2022

82% decreased risk of reinfection among persons who were infected and then vaccinated.

Friday, 11th February 2022

Association of BNT162b2 COVID-19 Vaccination During Pregnancy With Neonatal and Early Infant Outcomes.

COVID

Saturday, 22nd January 2022

Our new joint study in collaboration with Yale: Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel.

Thursday, 9th December 2021

Waning of SARS-CoV-2 booster viral-load reduction effectiveness.

Tuesday, 2nd November 2021

Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine.

COVID

Tuesday, 2nd November 2021

Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2.

Sunday, 19th September 2021

Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine.

Friday, 3rd September 2021

Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two and Three doses of Vaccine.

COVID

Thursday, 2nd September 2021

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections.

Wednesday, 1st September 2021

Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two and Three doses of Vaccine.

Friday, 27th August 2021

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections.